The revenue generated by the North America intrauterine contraceptive device market is projected to increase from $XX million in 2018 to $XX million by 2027, because of an expected CAGR growth of 3.55% over the forecast period 2019-2027. The markets of countries like the United States and Canada were studied for this region. The market is primarily being driven by the high rate of unplanned pregnancies among the teenage population and by the initiatives undertaken by the government to reduce these unplanned pregnancies and abortion across the region. North America intrauterine contraceptive devices market mainly covers the economic contribution of countries like the United States and Canada. North America intrauterine contraceptive market is driven by the increasing number of unplanned devices coupled with measures to control populations is boosting the intrauterine contraceptive devices market in the North America region during the forecast period of 2019-2027.
NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET FORECAST 2019-2027
North America Intrauterine Contraceptive Devices Market by Type (Copper Icd, Hormonal Icd) by Product (Mirena, Skyla, Paragard, Other Products) by Geography.
The revenue generated by the North America intrauterine contraceptive device market is projected to increase from $XX million in 2018 to $XX million by 2027, because of an expected CAGR growth of 3.55% over the forecast period 2019-2027.
The markets of countries like the United States and Canada were studied for this region. The market is primarily being driven by the high rate of unplanned pregnancies among the teenage population and by the initiatives undertaken by the government to reduce these unplanned pregnancies and abortion across the region. North America intrauterine contraceptive devices market mainly covers the economic contribution of countries like the United States and Canada. North America intrauterine contraceptive market is driven by the increasing number of unplanned devices coupled with measures to control populations is boosting the intrauterine contraceptive devices market in the North America region during the forecast period of 2019-2027.
In the year 2017, the government of Canada announced its first international assistance policy (for females), which is aimed at improving sexual and reproductive health care as well as safe abortion and contraception. This is predicted to increase the demand for the intrauterine contraceptive device market in the region.
Some of the key companies operating in this market include Teva Pharmaceutical Industries Limited, Trimedic Supply Network Ltd., OCON Medical Ltd., DKT International, Krishco Medical Products Pvt. Ltd., Melbea, Bayers AG, Merck & Co., Okamoto Industries Inc., Egemen International, Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., SMB Corporation, Pregna, Allergan PLC, HLL LifeCare Ltd., Medisafe Distribution Inc., Pfizer, Medicines360, Zhejiang Daji Medical Instruments Co., Ltd., and others.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP-DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- INCREASED FUNDING IS SUPPORTING PUBLIC AWARENESS
- INTRAUTERINE CONTRACEPTIVE DEVICE HAVE A LOW FAILURE RATE
- COPPER IUD HOLD THE LARGEST MARKET SHARE
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- RISING PREVALENCE OF UNPLANNED PREGNANCY
- TECHNOLOGICAL ADVANCEMENTS IN INTRAUTERINE CONTRACEPTIVE DEVICES
- MARKET RESTRAINTS
- HIGH COST OF TREATMENT
- LOW ADOPTION OF INTRAUTERINE CONTRACEPTION IN DEVELOPING COUNTRIES
- MARKET OPPORTUNITIES
- RATE OF UNINTENDED PREGNANCIES IS VERY HIGH
- VERY LOW FAILURE RATE OF IUD AND LOW SIDE-EFFECTS
- MARKET CHALLENGES
- HIGH RISK OF ECTOPIC PREGNANCY
- MARKET BY TYPE
- COPPER ICD
- HORMONAL ICD
- MARKET BY PRODUCT
- MIRENA
- SKYLA
- PARAGARD
- OTHER PRODUCTS
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF BUYERS
- THREAT OF COMPETITIVE RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- COMPANY PROFILES
- ALLERGAN PLC
- BAYERS AG
- HLL LIFECARE LTD.
- PFIZER
- MERCK & CO.
- OCON MEDICAL LTD.
- DKT INTERNATIONAL
- PREGNA
- SMB CORPORATION
- OKAMOTO INDUSTRIES INC.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- EGEMEN INTERNATIONAL
- MEDISAFE DISTRIBUTION INC.
- MELBEA
- KRISHCO MEDICAL PRODUCTS PVT. LTD.
- ZHEJIANG DAJI MEDICAL INSTRUMENTS CO., LTD.
- MERIL LIFE SCIENCES PVT. LTD.
- MONA LISA N.V.
- TRIMEDIC SUPPLY NETWORK LTD.
- MEDICINES360
- COMPANY PROFILES
TABLE LIST
TABLE 1. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2019-2027 (IN $ BILLION)
TABLE 2. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2019-2027 (IN $ BILLION)
TABLE 3. NORTH AMERICA COPPER ICD MARKET, BY REGION, 2019-2027 (IN $ BILLION)
TABLE 4. NORTH AMERICA HORMONAL ICD MARKET, BY REGION, 2019-2027 (IN $ BILLION)
TABLE 5. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PRODUCT, 2019-2027 (IN $ BILLION)
TABLE 6. NORTH AMERICA MIRENA MARKET, BY REGION, 2019-2027 (IN $ BILLION)
TABLE 7. NORTH AMERICA HARDWARE MARKET, BY REGION, 2019-2027 (IN $ BILLION)
TABLE 8. NORTH AMERICA PARAGARD MARKET, BY REGION, 2019-2027 (IN $ BILLION)
TABLE 9. NORTH AMERICA OTHER PRODUCTS MARKET, BY REGION, 2019-2027 (IN $ BILLION)
TABLE 10. OPPORTUNITY MATRIX
TABLE 11. VENDOR LANDSCAPE
TABLE 12. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2019-2027, (IN $ BILLION)
TABLE 13. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COUNTRY, 2019-2027 (IN $ BILLION)
FIGURE LISTÂ
FIGURE 1. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2018 & 2027 (IN %)
FIGURE 2. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COPPER ICD, 2019-2027 (IN $ BILLION)
FIGURE 3. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY HORMONAL ICD, 2019-2027 (IN $ BILLION)
FIGURE 4. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY MIRENA, 2019-2027 (IN $ BILLION)
FIGURE 1. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY SKYLA, 2019-2027 (IN $ BILLION)
FIGURE 2. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PARAGARD, 2019-2027 (IN $ BILLION)
FIGURE 3. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY OTHER PRODUCTS, 2019-2027 (IN $ BILLION)
FIGURE 4. PORTER’S FIVE FORCE ANALYSIS
FIGURE 5. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 6. UNITED STATES INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
FIGURE 7. CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY TYPE
- COPPER ICD
- HORMONAL ICD
- MARKET BY PRODUCT
- MIRENA
- SKYLA
- PARAGARD
- OTHER PRODUCTS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.